Drugs / PF-05241328
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01165736 Comparator | Jul → Aug 2010 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-05241328 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01165736 ↗ |
| Modality | Small molecule | — CHEMBL4279521 ↗ |
| Route | Intravenous | “single intravenous infusion of 100 microgram PF-05241328” NCT01165736 ↗ |